Results 251 to 260 of about 1,922,670 (308)
Recent Advances in the Application of Nitro(het)aromatic Compounds for Treating and/or Fluorescent Imaging of Tumor Hypoxia. [PDF]
Anichina K +4 more
europepmc +1 more source
Investigating the effects of stereotactic body radiation therapy on pancreatic tumor hypoxia and microvasculature in an orthotopic mouse model using intravital fluorescence microscopy. [PDF]
Samuel T +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Molecular Imaging and Biology, 2010
There is a need to measure tumor hypoxia in assessing the aggressiveness of tumor and predicting the outcome of therapy. A number of invasive and noninvasive techniques have been exploited to measure tumor hypoxia, including polarographic needle electrodes, immunohistochemical staining, radionuclide imaging (positron emission tomography [PET] and ...
Xilin, Sun +4 more
openaire +2 more sources
There is a need to measure tumor hypoxia in assessing the aggressiveness of tumor and predicting the outcome of therapy. A number of invasive and noninvasive techniques have been exploited to measure tumor hypoxia, including polarographic needle electrodes, immunohistochemical staining, radionuclide imaging (positron emission tomography [PET] and ...
Xilin, Sun +4 more
openaire +2 more sources
Hypoxia and the Tumor Secretome
2019Metastasis remains the leading cause of cancer-related deaths. To date, there are no specific treatments targeting disseminated disease. New therapeutic options will become available only if we enhance our understanding of mechanisms underlying metastatic spread.
Ying, Liu +2 more
openaire +2 more sources
Hypoxia and hypoxia inducible factors in tumor metabolism
Cancer Letters, 2015Because of the abnormal vasculature, most growing solid tumors contain regions that experience either acute or chronic hypoxia. However, tumor cells can maintain a high glycolytic rate even when there is enough oxygen supply. Hypoxia-inducible factors (HIFs) play crucial role in the response of tumor cells to this distinct microenvironment by shifting ...
Wen, Zeng +4 more
openaire +2 more sources
Seminars in Nuclear Medicine, 2001
For many years, it has been known that hypoxia affects the response to radiotherapy in human cancers. Hypoxic regions can develop as a tumor grows beyond the ability of its blood supply to deliver oxygen to the full extent of the tumor, exacerbated by vascular spasm or compression caused by increased interstitial fluid pressure.
openaire +2 more sources
For many years, it has been known that hypoxia affects the response to radiotherapy in human cancers. Hypoxic regions can develop as a tumor grows beyond the ability of its blood supply to deliver oxygen to the full extent of the tumor, exacerbated by vascular spasm or compression caused by increased interstitial fluid pressure.
openaire +2 more sources
Hypoxia-inducible factors, hypoxia, and tumor angiogenesis
Current Opinion in Hematology, 2006The transcription factor hypoxia-inducible factor is activated by low oxygen to promote the expression of target genes that allow cellular, tissue, and organismal adaptation to low oxygen. Hypoxia-inducible factor is activated not only by hypoxia but also as a consequence of genetic mutations in a variety of tumors.
Michaela, Gruber, M Celeste, Simon
openaire +2 more sources
Imaging hypoxia and angiogenesis in tumors
Radiologic Clinics of North America, 2005There is a clear need in cancer treatment for a noninvasive imaging assay that evaluates the oxygenation status and heterogeneity of hypoxia and angiogenesis in individual patients. Such an assay could be used to select alternative treatments and to monitor the effects of treatment.
Joseph G, Rajendran, Kenneth A, Krohn
openaire +2 more sources
Hypoxia imaging in brain tumors
Neuroimaging Clinics of North America, 2002Assessment of the oxygenation status of brain tumors has been studied increasingly with imaging techniques in light of recent advances in oncology. Tumor oxygen tension is a critical factor influencing the effectiveness of radiation and chemotherapy and malignant progression.
F Zerrin, Yetkin, Dianne, Mendelsohn
openaire +2 more sources

